Search research articles
Contact Us
Filters
Showing results (111-120 of 119) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 119 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2021
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL
Regina M Myers, Agne Taraseviciute, Seth M Steinberg, et al.
Blood Advances
|
April 28, 2022
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
Adam J Lamble, Regina M Myers, Agne Taraseviciute, et al.
Leukemia
|
September 11, 2024
Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study
Susan R Rheingold, Deepa Bhojwani, Lingyun Ji, et al.
The New England Journal of Medicine
|
December 9, 2024
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
Sumit Gupta, Rachel E Rau, John A Kairalla, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2020
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study
Michael J Burke, Rumen Kostadinov, Richard Sposto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
Cancer Discovery
|
February 10, 2021
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium
Yana Pikman, Sarah K Tasian, Maria Luisa Sulis, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 119) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 119 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2021
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL
Regina M Myers, Agne Taraseviciute, Seth M Steinberg, et al.
Blood Advances
|
April 28, 2022
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
Adam J Lamble, Regina M Myers, Agne Taraseviciute, et al.
Leukemia
|
September 11, 2024
Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study
Susan R Rheingold, Deepa Bhojwani, Lingyun Ji, et al.
The New England Journal of Medicine
|
December 9, 2024
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
Sumit Gupta, Rachel E Rau, John A Kairalla, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2020
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study
Michael J Burke, Rumen Kostadinov, Richard Sposto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
Cancer Discovery
|
February 10, 2021
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium
Yana Pikman, Sarah K Tasian, Maria Luisa Sulis, et al.
Page
of 12